Gene Query: SAFB2

Dataset Description Geneva Score
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 48.62
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 40.77
Uridylation by TUT4 and TUT7 marks mRNA for degradation 23.46
Zika infected neural stem cells 21.85
Transcriptome analysis of Zika infected neural stem cells 21.85
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 21.06
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 20.72
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 20.72
FBXW7 modulates stress response by post-translational modification of HSF1 18.07
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 18.07
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 18.07
RNA-seq analysis of uveal melanoma cells treated with FR900359 17.88
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 17.67
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 17.49
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 17.32
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 16.88
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 16.73
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 16.6
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 16.53
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 16.09
Effect of FGF13 depletion on the H460 cell line 15.29
MOF acetyl transferase regulates transcription and respiration in mitochondria 15.18
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 15.1
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.94
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 14.92
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 14.74
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 14.42
14.03
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 14.03
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.97
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 13.84
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 13.43
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 13.31
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 13.14
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 13.02
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 12.81
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 12.76
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 12.76
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 12.14
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 12.1
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 12.02
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 12.02
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 11.97
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.91
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 11.89
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 11.38
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 11.3
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 11.18
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 11.18
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 11.12
METTL3 promotes translation in human cancer cells 11.1
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 10.94
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 10.94
Small-molecule targeting of brachyury transcription factor addiction in chordoma 10.72
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 10.68
Cell responses to dysregulated VZV-induced cell-cell fusion 10.57
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 10.46
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 10.46
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 10.4
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 10.4
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 10.39
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 10.28
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 10.24
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 10.24
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 10.21
Differential gene expression of human melanoma cells [RNA-seq] 10.17
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 10.17
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 10.12
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.07
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 10.03
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 9.95
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 9.93
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 9.9
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 9.9
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 9.9
R430: A potent inbibitor of DNA and RNA viruses 9.82
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 9.8
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 9.77
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 9.73
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 9.67
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 9.56
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 9.48
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 9.45
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 9.45
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 9.31
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 9.27
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 9.25
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 9.07
Transcriptome analysis of SKI knock-out in HL60 cells 9.07
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 9.06
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 8.94
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 8.89
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 8.86
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 8.81
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 8.81
Intrahepatic MAIT cell gene expression revealed by RNA-seq 8.8
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.69
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 8.62
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 8.6
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 8.57
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 8.56
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 8.56
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 8.51
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.46
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 8.4
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 8.36
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.35
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 8.33
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 8.33
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 8.27
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 8.24
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 8.24
Human embryonic stem cells in E8 and AKIT culture medium 8.18
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 8.18
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 8.14
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 8.02
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 8.02
Paxillin regulates genomic networks in prostate cancer [PC3] 8.0
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.99
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 7.98
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.97
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.87
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 7.81
High-throughput sequencing of pluripotent cells 7.71
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 7.69
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 7.69
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.64
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.62
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 7.6
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 7.6
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.56
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.56
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 7.53
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 7.53
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 7.53
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 7.51
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.45
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 7.42
Maturation of human iNSCs 7.42
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 7.41
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 7.39
Selective suppression of endothelial cytokine production by progesterone receptor 7.37
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 7.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 7.34
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.31
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.31
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.3
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 7.27
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 7.2
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 7.2
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 7.16
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 7.16
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 7.1
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 7.08
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 7.08
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.07
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.07
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 7.07
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 7.06
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 6.99
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 6.97
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.95
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.94
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.94
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.93
Transcriptional profiling of LS1034 cells treated with tepoxalin 6.93
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 6.91
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 6.84
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.8
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 6.8
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 6.74
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 6.73
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.42
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 6.35
RNA-seq of young and quiescent MRC-5 human fibroblasts 6.34
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.32
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.32
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 6.31
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.25
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 6.24
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 6.23
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.22
NKX2.2 6.21
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 6.21
Glioblastoma stem cells infected by ZIKA virus 6.19
High-Throughput Kinetic Analysis of Fractional Killing 6.19
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 6.13
In situ CAPTURE of chromatin interactions by biotinylated dCas9 6.09
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 6.09
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 6.06
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 6.06
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.05
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.04
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.04
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 6.03
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 6.01
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 6.01
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.98
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.98
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.97
Total RNA-seq in ALL-SIL upon JQ1 inhibition 5.94
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.93
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 5.88
The interplay between SOX4 and SMAD3 in the context of breast cancer 5.88
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 5.87
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 5.87
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.83
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 5.82
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.81
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.79
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.78
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.76
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 5.71
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.67
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 5.64
The DPYSL2 gene connects mTOR and schizophrenia 5.62
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.6
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.58
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.58
RNA-seq of naive and primed ES cells (NHSM) 5.56
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 5.53
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.51
RNAseq Study in CC-671 Treated Cal-51 Cells 5.49
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.47
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.47
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 5.47
TFAP2C signalling in human fibroblasts 5.47
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.46
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 5.44
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 5.4
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 5.4
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.37
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.37
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.31
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 5.29
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 5.27
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 5.26
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.24
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 5.19
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 5.18
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 5.18
MicroRNA targetome analysis during HCMV infection 5.17
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.15
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.14
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.1
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 5.03
HEXIM1 is induced by DHODH inhibition to suppress melanoma 5.03
scRNASeq analysis of cycling cardiomyocytes 4.99
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.94
UV_24h_GRO-Seq 4.91
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 4.89
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 4.89
Loss of CREBBP results in gene expression repression in lymphoma cells 4.84
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.84
HEK293 TFAM Knockout Expression Study 4.74
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.73
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 4.72
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 4.68
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 4.68
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 4.59
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 4.59
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.59
Regulation of poly(A) tail and translation during the somatic cell cycle 4.53
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 4.52
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 4.52
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 4.52
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 4.52
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 4.52
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.51
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.51
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.51
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.5
MicroRNA-125a-5p overexpression in human macrophages 4.48
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 4.47
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 4.45
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.29
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 4.29
Transcriptomic analysis of human tonsillar TFH subsets 4.28
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 4.21
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.19
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.18
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 4.18
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 4.13
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 4.12
Mapping interactions for the TNIP2 hub protein 4.1
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.1
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.07
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.07
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.99
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 3.98
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 3.95
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 3.93
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.86
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.86
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.83
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 3.8
Transcriptomic analysis of LSD1 3.8
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.78
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.78
Identification of Atrial Fibrillation associated genes and functional non-coding variants 3.74
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 3.72
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.68
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.65
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 3.64
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.58
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 3.54
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.51
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.51
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.48
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.47
Capturing the Interactome of Newly Transcribed RNA 3.47
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.44
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.41
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.39
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 3.36
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.35
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.35
Illumina Total RNA-seq in HeLa 3.35
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.31
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 3.24
Modulation of nonsense-mediated decay by rapamycin 3.21
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.18
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.17
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 3.14
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 3.14
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.12
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 3.11
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 3.09
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 3.08
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 3.06
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.04
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.04
Single-cell analysis of adult human ovary using 10X genomics 3.02
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.96
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.94
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.93
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.91
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.91
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.88
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.87
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.85
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.79
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.77
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.75
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.75
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.75
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.73
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.69
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.69
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 2.68
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.66
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.66
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.65
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.64
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.64
RNAseq in Alzheimer's Disease patients 2.63
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.62
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.62
Effect of ILF3 on translation during homeostasis and the antiviral response 2.6
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.6
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.58
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.57
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 2.55
RNA Seq of HMVEC under hypoxia 2.55
Recovery and analysis of nascent RNA 2.55
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.55
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.48
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.44
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.43
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 2.43
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.42
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.42
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.38
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.38
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.36
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.36
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.35
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.33
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.3
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.29
Transposon-based construction of strand-specific RNA-seq libraries 2.28
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 2.28
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.27
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.27
Downregulation of LATS kinases alters p53 to promote cell migration 2.24
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.21
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.2
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.19
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.18
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 2.14
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.08
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.07
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.06
O-glcnAc reprograms cellular energetics 2.05
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.97
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.97
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.94
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.94
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.9
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.89
RNA-seq analysis of BAP1-depleted uveal melanoma cells 1.88
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.79
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.79
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.77
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.77
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.66
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.61
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.61
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.61
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.61
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.55
Dermal endothelial cells of type 2 diabetic patients 1.49
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.49
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.48
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.48
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.41
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 1.39
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 1.39
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.38
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.37
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.37
Unique features and clinical importance of acute alloreactive immune responses 1.37
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.36
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.31
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.29
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.25
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.25
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.21
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.17
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.1
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 1.1
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.1
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.1
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.08
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.02
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.02
SNHG5 siRNA knock down in HCT116 cells 1.01
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.9
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.88
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 0.88
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 0.88
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.87
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.87
RNA-seq of primary patient AML samples 0.85
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.84
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.77
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.72
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.72
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.7
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.67
6mer seed toxicity in viral microRNAs 0.67
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.66
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.65
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.62
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.59
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.58
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.54
Profiling of escape kinetics of viruses subjected to RNAi 0.52
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.49
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.45
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.44
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.43
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.39
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.38
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.36
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.34
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.34
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.32
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.32
Aging-associated patterns in the expression of human endogenous retroviruses 0.29
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.29
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.26
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.26
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.24
ETV7 and interferon response 0.24
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 0.24
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.21
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.21
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.15
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.15
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.13
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.13
STX4 Over-Expression in Human islets 0.13
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.13
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.13
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.09
Iron response of HepG2 cells 0.09
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.07
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.07
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.05
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.04
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.04
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.02
BACH2 in human plasma cell fate decision 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation